Breaking News Instant updates and real-time market news.

MMSI

Merit Medical

$31.55

0.2 (0.64%)

16:02
03/20/17
03/20
16:02
03/20/17
16:02

Merit Medical files to sell $125M in common stock

Merit expects to use the net proceeds from the offering to repay debt under its existing credit facility. BofA Merrill Lynch and Piper Jaffray & Co. are acting as joint book-running managers and representatives of the underwriters for the offering. Wells Fargo Securities is also acting as a joint book-running manager. Canaccord Genuity, Raymond James, and SunTrust Robinson Humphrey are acting as co-managers.

MMSI Merit Medical
$31.55

0.2 (0.64%)

07/28/16
BRRR
07/28/16
DOWNGRADE
BRRR
Market Perform
Merit Medical downgraded to Market Perform from Outperform at Barrington
07/28/16
BRRR
07/28/16
DOWNGRADE
BRRR
Market Perform
Merit Medical downgraded to Market Perform at Barrington
As previously reported, Barrington analyst Michael Petusky downgraded Merit Medical to Market Perform from Outperform, citing his view that near-term price appreciation will be limited following the stock's 50% rally from its February lows.
10/24/16
ADAM
10/24/16
NO CHANGE
Target $29
ADAM
Buy
Merit Medical weakness a buying opportunity, says Canaccord
Canaccord analyst Jason Mills noted Merit Medical announced a DOJ investigation, which will probably lead to weakness in its shares. The analyst said the type of investigation is becoming more commonplace in the med-tech industry and more often than not leads to a an opportunity for investors to make money. Mills would be an opportunistic buyer of the shares and believes the company is set to report another solid quarter. Mills reiterated his Buy rating and $29 price target on Merit Medical shares.
02/22/17
ADAM
02/22/17
NO CHANGE
Target $35
ADAM
Buy
Merit Medical price target raised to $35 from $29 at Canaccord
Canaccord analyst Jason Mills raised his price target to $35 from $29 on Merit Medical shares following Q4 results. The analyst cited outstanding guidance, impressive gross margins, controlled operating expenses, and a continual shift toward higher gross margin products. Mills reiterated his Buy rating on Merit Medical shares.

TODAY'S FREE FLY STORIES

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.